ARCHIVES

Dendritic Cell Vaccine May Boost Median Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Barbara Britt Assumes ONS Presidency, O’Conner Is President-Elect; Kalt Joins NCI

May 25, 1990

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

October 28, 2011

Surgeon General Issues Call To Reduce Skin Cancer Rates

August 1, 2014

In Brief: Baltimore Names ACS Research Professor; Currie, Sachdeva Lead Education Association

December 9, 1994

Agriculture Dept. Asks clearinghouse To Consider Broader Risk Assessment Data

July 14, 1978

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

April 21, 2006